Cartesian Therapeutics, Inc. (RNAC)
NASDAQ: RNAC · Real-Time Price · USD
14.54
+0.18 (1.25%)
At close: Mar 28, 2025, 4:00 PM
14.53
-0.01 (-0.05%)
After-hours: Mar 28, 2025, 7:56 PM EDT
Cartesian Therapeutics Market Cap
Cartesian Therapeutics has a market cap or net worth of $376.69 million as of March 28, 2025. Its market cap has increased by 322.77% in one year.
Market Cap
376.69M
Enterprise Value
178.06M
1-Year Change
322.77%
Ranking
Category
Stock Price
$14.54
Market Cap Chart
Since June 22, 2016, Cartesian Therapeutics's market cap has increased from $236.80M to $376.69M, an increase of 59.07%. That is a compound annual growth rate of 5.44%.
Market Cap History
Date | Market Cap | % Change |
---|---|---|
Mar 28, 2025 | 376.70M | -17.25% |
Dec 31, 2024 | 455.20M | 325.42% |
Dec 29, 2023 | 107.00M | -38.11% |
Dec 30, 2022 | 172.90M | -54.54% |
Dec 31, 2021 | 380.30M | 16.19% |
Dec 31, 2020 | 327.30M | 185.35% |
Dec 31, 2019 | 114.70M | 92.13% |
Dec 31, 2018 | 59.70M | -72.75% |
Dec 29, 2017 | 219.10M | -29.78% |
Dec 30, 2016 | 312.00M | 31.76% |
View and export this data all the way back to 2016.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
Eli Lilly and Company | 738.61B |
UnitedHealth Group | 472.03B |
Johnson & Johnson | 394.52B |
AbbVie | 363.15B |
Novo Nordisk | 305.46B |
AstraZeneca | 229.16B |
Abbott Laboratories | 226.88B |
Merck & Co. | 225.40B |